ATA93198A - Fluoxetinpellets - Google Patents

Fluoxetinpellets

Info

Publication number
ATA93198A
ATA93198A AT0093198A AT93198A ATA93198A AT A93198 A ATA93198 A AT A93198A AT 0093198 A AT0093198 A AT 0093198A AT 93198 A AT93198 A AT 93198A AT A93198 A ATA93198 A AT A93198A
Authority
AT
Austria
Prior art keywords
fluoxetinpellets
Prior art date
Application number
AT0093198A
Other languages
English (en)
Other versions
AT408068B (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25349313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA93198(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA93198A publication Critical patent/ATA93198A/de
Application granted granted Critical
Publication of AT408068B publication Critical patent/AT408068B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT0093198A 1997-05-29 1998-05-29 Fluoxetinpellets AT408068B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/867,196 US5910319A (en) 1997-05-29 1997-05-29 Fluoxetine enteric pellets and methods for their preparation and use

Publications (2)

Publication Number Publication Date
ATA93198A true ATA93198A (de) 2001-01-15
AT408068B AT408068B (de) 2001-08-27

Family

ID=25349313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0093198A AT408068B (de) 1997-05-29 1998-05-29 Fluoxetinpellets

Country Status (45)

Country Link
US (3) US5910319A (de)
JP (1) JP3210288B2 (de)
KR (1) KR100549473B1 (de)
CN (2) CN1161109C (de)
AR (1) AR011728A1 (de)
AT (1) AT408068B (de)
AU (1) AU726690B2 (de)
BE (1) BE1011925A3 (de)
BR (1) BR9801989A (de)
CA (1) CA2234826C (de)
CH (1) CH693018A5 (de)
CO (1) CO4940407A1 (de)
CZ (1) CZ290582B6 (de)
DE (1) DE19823940B4 (de)
DK (1) DK176776B1 (de)
ES (1) ES2161574B1 (de)
FI (1) FI119971B (de)
FR (1) FR2763846B1 (de)
GB (1) GB2325623B (de)
GR (1) GR980100188A (de)
HU (1) HUP9800882A3 (de)
ID (1) ID20343A (de)
IL (1) IL124073A (de)
IT (1) ITMI980908A1 (de)
LT (1) LT4477B (de)
LU (1) LU90245B1 (de)
LV (1) LV12176B (de)
MY (1) MY118139A (de)
NL (1) NL1009259C2 (de)
NO (1) NO317743B1 (de)
NZ (1) NZ330192A (de)
PE (1) PE75399A1 (de)
PL (1) PL192293B1 (de)
PT (1) PT102152B (de)
RO (1) RO120043B1 (de)
RS (1) RS49827B (de)
RU (1) RU2164405C2 (de)
SE (1) SE522914C2 (de)
SG (1) SG72805A1 (de)
SI (1) SI9800128B (de)
SV (1) SV1998000052A (de)
TR (1) TR199800937A3 (de)
TW (1) TWI239838B (de)
UA (1) UA48193C2 (de)
ZA (1) ZA983173B (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
ES2290027T3 (es) * 1999-05-20 2008-02-16 Elan Corporation, Plc Formulaciones multiparticuladas y de liberacion controlada de inhibidores selectivos de la recaptacion de serotonina.
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
BR0014166A (pt) 1999-09-03 2002-05-14 Lilly Co Eli Método de utilização de inibidores de reabsorção de serotonina seletivo de rápido ataque para tratamento de disfunção sexual
CN1094347C (zh) * 1999-11-15 2002-11-20 广东药学院药物研究所 一种治疗前列腺良性增生症的控释微丸及其制备方法
US6273260B1 (en) 2000-03-08 2001-08-14 Eli Lilly And Company Pharmaceutical packaging system
ES2185452B2 (es) * 2000-08-01 2004-03-16 Cinfa S A Lab Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
JP4181738B2 (ja) * 2000-08-25 2008-11-19 信越化学工業株式会社 腸溶性コーティング製剤の製造方法
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
WO2002038126A2 (en) * 2000-11-08 2002-05-16 Aeromatic-Fielder Ag A process for production of particles for pharmaceutical compositions having increased bioavailability
WO2003013480A1 (en) 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
US20040170688A1 (en) * 2001-08-06 2004-09-02 Deshmukh Abhijit Mukund Enteric formulation of fluoxetin
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
AU2002361495A1 (en) * 2002-12-24 2004-07-22 Lupin Limited Enteric coated fluoxetine composition
US8614247B2 (en) * 2003-04-10 2013-12-24 Institut National De La Sante Et De La Recherche Medicale Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof
NZ577031A (en) 2003-05-30 2010-09-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-CO inhibitors
US20050176693A1 (en) * 2003-08-12 2005-08-11 Boissonneault Roger M. Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle
WO2005065726A1 (en) * 2003-12-30 2005-07-21 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition
EP1787640A4 (de) * 2004-04-30 2012-04-11 Astellas Pharma Inc Körnige pharmazeutische zusammensetzung mit zeitbegrenzter abgabe zur oralen verabreichung und schnellzerfallende intraorale tablette mit der zusammensetzung
KR100920856B1 (ko) * 2004-11-30 2009-10-09 (주)아모레퍼시픽 선택적 세로토닌 재흡수 억제제의 연장방출 제제 및 그제조방법
WO2006071868A2 (en) * 2004-12-23 2006-07-06 Teva Pharmaceutical Industries Ltd. Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
WO2007015270A2 (en) * 2005-08-02 2007-02-08 Lupin Limited Novel controlled release compositions of selective serotonin reuptake inhibitors
WO2007054896A1 (en) 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
CA2629800A1 (en) * 2005-11-23 2007-05-31 Thomas G. Gant Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
US7759500B2 (en) * 2005-12-05 2010-07-20 Teva Pharmaceutical Industries Ltd. 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride
US20080033030A1 (en) * 2006-02-24 2008-02-07 Capua Simona D Fluvastatin sodium pharmaceutical compositions
CN101057837B (zh) * 2006-04-20 2010-12-22 湖南九典制药有限公司 一种右旋酮洛芬肠溶微丸及制备方法
WO2007134168A2 (en) * 2006-05-10 2007-11-22 Dr. Reddy's Laboratories Ltd. Process for preparing duloxetine
KR20090005237A (ko) * 2006-05-22 2009-01-12 테바 파마슈티컬 인더스트리즈 리미티드 둘록세틴 염산염 지연 방출형 제제
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
WO2008014175A2 (en) * 2006-07-28 2008-01-31 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
WO2008020286A2 (en) * 2006-08-14 2008-02-21 Torrent Pharmaceuticals Limited Pharmaceutical compositions of duloxetine
AU2007299726A1 (en) * 2006-09-22 2008-03-27 Braincells, Inc. Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
US20080226711A1 (en) * 2007-03-12 2008-09-18 Torrent Pharmaceuticals Ltd. Pharmaceutical compositions of duloxetine
US20090226517A1 (en) * 2008-02-06 2009-09-10 Vinita Umashankar Vyas Pharmaceutical formulations comprising duloxetine
MY156288A (en) 2008-07-16 2016-01-29 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands.
JPWO2010026993A1 (ja) * 2008-09-03 2012-02-02 武田薬品工業株式会社 製剤における吸収性改善方法および吸収性が改善された製剤
CN101804145B (zh) * 2009-02-12 2012-11-14 杭州赛利药物研究所有限公司 一种大蒜油肠溶微丸胶囊及其制备方法
EP2477614A2 (de) * 2009-09-17 2012-07-25 Cadila Healthcare Limited Pharmazeutische zusammensetzungen zur reduktion von alokoholinduzierter schneller dosisfreisetzung
JP5749247B2 (ja) 2010-02-22 2015-07-15 第一三共株式会社 経口用徐放性固形製剤
RU2442572C1 (ru) * 2010-12-23 2012-02-20 Ольга Львовна Титова Энтеросолюбильная оболочка и композиция для ее получения
ES2728850T3 (es) 2012-05-02 2019-10-29 Capsugel Belgium Nv Dispersiones acuosas de acetato acetato succinato de hidroxipropilmetilcelulosa (HPMCAS)
CN102716084B (zh) * 2012-06-29 2013-09-25 海南美大制药有限公司 盐酸氟西汀脂质体固体制剂
RU2665372C2 (ru) 2012-09-03 2018-08-29 Дайити Санкио Компани, Лимитед Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
US9782356B2 (en) 2014-05-20 2017-10-10 Dow Global Technologies Llc Capsule shells comprising an esterified cellulose ether
CN106413693B (zh) 2014-05-20 2018-08-24 陶氏环球技术有限责任公司 包含部分中和的酯化纤维素醚的分散体
WO2015187874A1 (en) * 2014-06-07 2015-12-10 Structure-Ase, Inc. A method for the detection and/or diagnosis of eating disorders and malnutrition using x-ray diffraction
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US11318122B2 (en) 2017-04-13 2022-05-03 Chase Therapeutics Corporation Pharmaceutical combination and its use for treating synucleinopathties
HUP1700253A1 (hu) 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
CN107898942B (zh) * 2017-11-24 2021-01-26 一力制药(罗定)有限公司 一种感冒清热胶囊及其制备方法
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
JP7606825B2 (ja) * 2020-06-15 2024-12-26 東和薬品株式会社 エソメプラゾール顆粒ならびにその製造方法および用途
WO2022115054A1 (en) * 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Enteric coated duloxetine compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194009A (en) 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
JPS517116A (en) 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
CH649216A5 (de) 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
JPS5855125B2 (ja) * 1980-03-10 1983-12-08 信越化学工業株式会社 固形薬剤用腸溶性コ−テイング剤組成物
US4444778A (en) * 1981-08-27 1984-04-24 Coughlin Shaun R Method and composition for treating atherosclerosis
US4797286A (en) 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4847092A (en) * 1985-11-12 1989-07-11 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US4918242A (en) 1988-03-30 1990-04-17 Aldrich Chemical Company, Inc. Novel optically 1,3-phenoxypropylhalides
CA1337955C (en) * 1988-09-26 1996-01-23 Thomas A. Almquist Recoating of stereolithographic layers
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5104899A (en) * 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
JPH04202124A (ja) * 1990-11-29 1992-07-22 Fuji Kagaku Kogyo Kk 噴霧乾燥造粒法による薬物放出の制御された製剤の製造法
WO1992013452A1 (en) * 1991-02-04 1992-08-20 Young James W Methods of use and compositions of r(-) fluoxetine
WO1992019241A1 (en) * 1991-05-07 1992-11-12 Dynagen, Inc. A controlled, sustained release delivery system for smoking cessation
ATE173159T1 (de) * 1992-03-25 1998-11-15 Depomed Systems Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
JPH06293633A (ja) * 1993-04-05 1994-10-21 Shin Etsu Chem Co Ltd 水性腸溶性エマルジョンの製造方法
US5362886A (en) 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
DE69426570T2 (de) * 1993-11-03 2001-08-23 Isomed, Inc. Mizelleförmige feinteilige pharmazeutische zusammensetzungen
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JPH08109126A (ja) * 1994-10-07 1996-04-30 Amano Pharmaceut Co Ltd 耐衝撃性腸溶性顆粒剤およびこれを含有する錠剤
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
SE9801336D0 (sv) 1998-04-17
ZA983173B (en) 1999-10-15
AR011728A1 (es) 2000-08-30
RS49827B (sr) 2008-08-07
SI9800128B (sl) 2000-04-30
ITMI980908A1 (it) 1999-10-28
CZ114398A3 (cs) 1998-12-16
FR2763846A1 (fr) 1998-12-04
KR19980086622A (ko) 1998-12-05
ES2161574A1 (es) 2001-12-01
USRE39030E1 (en) 2006-03-21
SE522914C2 (sv) 2004-03-16
CN1200924A (zh) 1998-12-09
TR199800937A2 (xx) 1999-10-21
DK176776B1 (da) 2009-08-10
CN1212834C (zh) 2005-08-03
PT102152B (pt) 2000-09-29
TR199800937A3 (tr) 1999-10-21
RU2164405C2 (ru) 2001-03-27
JP3210288B2 (ja) 2001-09-17
PL192293B1 (pl) 2006-09-29
AT408068B (de) 2001-08-27
FI980846A0 (fi) 1998-04-16
SE9801336L (sv) 1998-11-30
SV1998000052A (es) 1999-03-16
MY118139A (en) 2004-09-30
CN1161109C (zh) 2004-08-11
LU90245A1 (de) 1998-11-30
GB2325623A (en) 1998-12-02
GB9807939D0 (en) 1998-06-10
HUP9800882A3 (en) 2000-07-28
US5985322A (en) 1999-11-16
DE19823940B4 (de) 2010-04-29
UA48193C2 (uk) 2002-08-15
AU6904898A (en) 1998-12-03
TWI239838B (en) 2005-09-21
LV12176A (lv) 1998-12-20
NO982197L (no) 1998-11-30
HU9800882D0 (en) 1998-05-28
IE980284A1 (en) 2000-07-12
GR980100188A (el) 1999-01-29
CA2234826C (en) 2000-12-19
YU16598A (en) 1999-11-22
HUP9800882A2 (hu) 2000-03-28
ID20343A (id) 1998-12-03
ES2161574B1 (es) 2002-06-16
LT4477B (lt) 1999-03-25
RO120043B1 (ro) 2005-08-30
LT98058A (en) 1998-10-26
GB2325623B (en) 1999-04-14
IL124073A (en) 2002-02-10
US5910319A (en) 1999-06-08
FR2763846B1 (fr) 2001-05-18
LV12176B (lv) 1999-03-20
FI119971B (fi) 2009-05-29
HK1034902A1 (en) 2001-11-09
BR9801989A (pt) 2000-02-08
FI980846L (fi) 1998-11-30
KR100549473B1 (ko) 2006-03-23
NL1009259C2 (nl) 1998-12-01
PT102152A (pt) 1998-12-31
NO317743B1 (no) 2004-12-13
NO982197D0 (no) 1998-05-14
CA2234826A1 (en) 1998-11-29
PE75399A1 (es) 1999-08-17
JPH10330253A (ja) 1998-12-15
AU726690B2 (en) 2000-11-16
BE1011925A3 (fr) 2000-03-07
SI9800128A (sl) 1999-02-28
DE19823940A1 (de) 1998-12-03
CO4940407A1 (es) 2000-07-24
SG72805A1 (en) 2000-05-23
LU90245B1 (fr) 2002-07-31
PL326134A1 (en) 1998-12-07
CN1285189A (zh) 2001-02-28
NZ330192A (en) 1999-08-30
CH693018A5 (de) 2003-01-31
CZ290582B6 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
DE19810476B4 (de) Laryngomaske
DE59806832D1 (de) Zementationshilfsmittel
ATA93198A (de) Fluoxetinpellets
DE59806720D1 (de) Einspritzventil
DE59803185D1 (de) Baulaser
ATA111897A (de) Kimme
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE59804631D1 (de) Diketopyrrolopyrrolzusammensetzungen
DE59804377D1 (de) Kryoventil
DE59801498D1 (de) Dioxacycloalkan-8-one
DE59710388D1 (de) Mikropolarimeter
DE59805979D1 (de) Organosilan-oligomere
DE59806387D1 (de) Azofarbstoffmischungen
DE59807879D1 (de) 3-benzylpiperidine
DE69804086D1 (de) Transientbildstruktur
DE59806790D1 (de) Acrylesterkautschukpartikel
ATA112597A (de) Snowboard - bindung
DE59806501D1 (de) Spitzenschneider
DE59805424D1 (de) Transversalmodenresonatorfilter
DE59806025D1 (de) Normalsäschar
FI973848A0 (fi) Baerbar faeltprocesseringsanordning
DE59805053D1 (de) Bogenflexodruckmaschine
ATA46498A (de) Kunststoffgleitbahn
ATA86797A (de) Verschleissschuh
NO980984L (no) Krustebryteanordning

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
MK07 Expiry

Effective date: 20180529